In conclusion, we validated the use of the 5-point screen as a screening tool for immediate decision making in remote areas. We found that patients positive for COVID-19 receive low scores on the hantavirus 5-point screen, thus validating its use as a rapid tool to differentiate between these two disease entities in hantavirus endemic areas.
This project was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the Centers for Disease Control and Prevention.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Am J Clin Pathol. 2022;157(3):470-475. © 2022 American Society for Clinical Pathology